We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+1.74%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$5.07B
AUM Growth
+$233M
Cap. Flow
+$256M
Cap. Flow %
5.04%
Top 10 Hldgs %
8.61%
Holding
1,586
New
113
Increased
363
Reduced
281
Closed
96

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$25.3M
2
HUM icon
Humana
HUM
+$22.7M
3
ALLY icon
Ally Financial
ALLY
+$21.8M
4
CL icon
Colgate-Palmolive
CL
+$21.4M
5
NEM icon
Newmont
NEM
+$20.4M

Sector Composition

Rank Sector Weight
1 Financials 20.89%
2 Industrials 13.68%
3 Healthcare 13.14%
4 Technology 11.02%
5 Consumer Discretionary 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYBE
951
DELISTED
Cyberoptics Corp
CYBE
$646K 0.01%
63,900
GORO icon
952
Goldgroup Mining Inc.
GORO
$157M
$645K 0.01%
233,600
+89,100
+62% +$286K
WLH
953
DELISTED
WILLIAM LYON HOMES
WLH
$642K 0.01%
25,000
AIOT
954
PowerFleet Inc
AIOT
$526M
$641K 0.01%
105,000
PLX icon
955
Protalix BioTherapeutics
PLX
$191M
$638K 0.01%
32,734
+2,651
+9% +$55K
DTLK
956
DELISTED
Datalink Corp
DTLK
$638K 0.01%
71,400
OMCC
957
DELISTED
Old Market Capital Corp
OMCC
$636K 0.01%
50,000
EFSC icon
958
Enterprise Financial Services Corp
EFSC
$2.4B
$635K 0.01%
27,900
-400
-1% -$8.56K
AEPI
959
DELISTED
AEP Industries Inc
AEPI
$629K 0.01%
11,400
DRNA
960
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$628K 0.01%
45,000
SNAK
961
DELISTED
Inventure Foods, Inc.
SNAK
$628K 0.01%
61,900
-15,000
-20% -$153K
AIRT icon
962
Air T
AIRT
$75.5M
$627K 0.01%
44,850
+4,500
+11% +$62.2K
RIGL icon
963
Rigel Pharmaceuticals
RIGL
$681M
$627K 0.01%
19,530
-230
-1% -$8.79K
SN
964
DELISTED
Sanchez Energy Corporation
SN
$627K 0.01%
64,000
-53,000
-45% -$641K
AMRS
965
DELISTED
Amyris Inc.
AMRS
$626K 0.01%
21,387
ASRV icon
966
AmeriServ Financial
ASRV
$77.5M
$625K 0.01%
187,671
SPWH icon
967
Sportsman's Warehouse
SPWH
$44.5M
$625K 0.01%
55,000
ARTNA icon
968
Artesian Resources
ARTNA
$355M
$624K 0.01%
29,600
-100
-0.3% -$2.15K
SHBI icon
969
Shore Bancshares
SHBI
$819M
$623K 0.01%
66,112
+20,000
+43% +$187K
WEYS icon
970
Weyco Group
WEYS
$372M
$623K 0.01%
20,883
-21,117
-50% -$613K
CEMP
971
DELISTED
Cempra, Inc.
CEMP
$618K 0.01%
18,000
+50
+0.3% +$1.77K
AMTX icon
972
Aemetis
AMTX
$106M
$616K 0.01%
171,039
+29,069
+20% +$127K
PZZA icon
973
Papa John's
PZZA
$984M
$616K 0.01%
8,145
-750
-8% -$50.1K
FGH
974
DELISTED
FG Group Holdings Inc.
FGH
$614K 0.01%
130,920
INSY
975
DELISTED
Insys Therapeutics, Inc.
INSY
$611K 0.01%
17,000
+800
+5% +$24.9K

Similar funds

Bridgeway Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Bridgeway Capital Management held 1,586 positions worth $5.07B, up 4.8% from $4.84B the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

Bridgeway Capital Management deployed $256M of net new capital in Q2 2015, opening 113 new positions and adding to 363 existing holdings. Its largest new stake was Humana: 122,463 shares worth $23.4M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $15.8M trimmed.

  • Bridgeway Capital Management's largest Q2 2015 buy was Humana: 122,463 shares worth $23.4M.
  • Bridgeway Capital Management added most to Johnson & Johnson in Q2 2015, an estimated $25.3M increase.
  • Bridgeway Capital Management's biggest Q2 2015 reduction was Amgen, cutting an estimated $15.8M.
  • Bridgeway Capital Management fully exited Alphabet (Google) Class C in Q2 2015, selling an estimated $24.7M.
  • Bridgeway Capital Management's ten largest holdings make up 8.6% of its $5.07B portfolio in Q2 2015.
  • Bridgeway Capital Management opened 113 new positions and closed 96 in Q2 2015.
  • Bridgeway Capital Management's portfolio value rose 4.8% quarter-over-quarter to $5.07B.

Based on Bridgeway Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.